Skip to main content
♕ The Globe and Mail Trade Off
Canada's free stock market contest is live! Test your investing skills for a chance to win $5,000.Enter Now!Enter Now!
➜

Curaleaf Celebrates President Trump's Landmark Rescheduling of Cannabis Under Controlled Substances Act

Newswire.ca - Thu Dec 18, 2025

Trump Administration's Rescheduling Opens New Avenues for Research, Medical Advancement, and Investment

STAMFORD, Conn., Dec. 18, 2025 /CNW/ -- Curaleaf Holdings, Inc. (TSX: CURA) (OTCQX: CURLF) ("Curaleaf" or the "Company"), a leading international provider of consumer cannabis products, today applauds the Trump Administration's action to implement the most impactful federal cannabis reform of the past fifty years by rescheduling cannabis as a Schedule III substance under the Controlled Substances Act of 1970.

Read more at newswire.ca

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).